Skip to main content

Advertisement

Open Peer Review Reports for: Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
21 Nov 2017 Submitted Original manuscript
27 Dec 2017 Author responded Author comments - Taro Iguchi
Resubmission - Version 2
27 Dec 2017 Submitted Manuscript version 2
26 Jul 2018 Reviewed Reviewer Report - Rahul Aggarwal
19 Jan 2019 Reviewed Reviewer Report - Laurence Krieger
6 Feb 2019 Author responded Author comments - Taro Iguchi
Resubmission - Version 3
6 Feb 2019 Submitted Manuscript version 3
20 Mar 2019 Reviewed Reviewer Report - Laurence Krieger
25 Mar 2019 Author responded Author comments - Taro Iguchi
Resubmission - Version 4
25 Mar 2019 Submitted Manuscript version 4
Publishing
27 Mar 2019 Editorially accepted
11 Apr 2019 Article published 10.1186/s12885-019-5526-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement